As reported in Jane’s International Defence Review; The Israel Defence Force (IDF) has developed and incorporated a range of innovative new medical devices that it believes will help save soldiers’ lives in future conflicts.
Much of the impetus behind the new technology came as a direct result of the lessons learned from operations in past conflicts the IDF has been involved in.
Among the first fruit of this process, in January the Medical Corps began equipping combat battalions with compact and portable battlefield respirators that can be used to resuscitate wounded soldiers on the battlefield. According to sources, as well as the micro-respirator being rolled out to the IDF, this system is in the advanced stages of securing approval from the FDA in the US.
The IDF Medical Corps is also exploring the possibility of developing specially-designed solar panels that can be sewed onto the top of tents in field hospitals to provide power for medical equipment. The IDF recently began distributing compact solar panel sheets to provide an energy source for infantry units behind enemy lines.
At 2008 the Medical Corps also began fielding the now widely used of Hemostatic combat dressing for the first time, with successful results in 14 different cases enhancing the coagulation of blood and preventing further loss. The Quick-Clot Combat Gauze was supplied to medics and field doctors. This bandage is designed to absorb the water molecules from the blood when in direct contact with an open wound. The larger platelets and clotting molecules remain in the wound in a highly concentrated form, promoting extremely rapid natural clotting and preventing sever blood loss.
Another product the IDF’s Medical Corp purchased is the Combat Application Tourniquet (CAT0 a lightweight one handed tourniquet that completely stops arterial blood flow.
The Medical Corps is also looking into a study about investigating the continued development of freeze-dry blood technology that will enable soldiers to carry a unit of their blood into battle. An Israeli Biotech company has already succeeded in drying and vacuum packing the blood, but is currently conducting tests to find the right fluid to return the dry blood to a liquid form.